ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
슬관절 점액낭염 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.8%로 37억 2,000만 달러로 성장할 것입니다. 예측 기간의 성장은 예방 및 관리에 대한 인식 제고 캠페인 증가, 가처분 소득 증가, 의료비 지출 증가, 슬관절 점액낭염에 대한 인식 및 진단 증가에 기인합니다. 예측 기간의 주요 동향으로는 진단 기술의 발전, 새로운 치료법 개발, 연구개발 활동의 발전, 원격의료 및 원격 모니터링 등을 들 수 있습니다.
향후 5년간 6.8%의 성장률 전망은 지난번 예측보다 0.5% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 한국이나 이탈리아에서 조달하는 치료용 초음파 장비와 부신피질 스테로이드 주사 키트 비용을 상승시키고, 통증 관리 일정을 장기화하며, 정형외과 클리닉의 지출을 증가시킴으로써 미국을 저해할 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
골다공증, 관절염, 골암 등 뼈 관련 질환의 유병률 증가는 향후 슬관절 점액낭염 시장 확대를 견인할 것으로 예상됩니다. 이들 질환은 골격계의 구조, 강도, 기능에 영향을 미치는 질환으로 고령화, 좌식 생활, 영양 부족, 환경 변화 등의 요인으로 인해 점점 더 만연하고 있습니다. 골관절염이나 류마티스 관절염과 같은 질환은 슬관절낭에 염증과 과도한 압박을 일으켜 통증, 부종, 관절 기능 저하를 초래하여 슬관절 점액낭염을 유발합니다. 예를 들어, Healthy Bones Australia는 2022년 9월에 호주에서 2022년에 골다공증 또는 골감소증을 앓고 있는 50세 이상 노인이 620만 명에 달할 것으로 예측하고 있으며, 뼈 건강 상태의 악화가 무릎 관련 증상에 큰 영향을 미친다는 점을 강조하고 있습니다. 따라서 뼈 관련 질환의 유병률 증가는 슬관절 점액낭염 시장의 성장 촉진요인으로 작용하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 슬관절 점액낭염 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 슬관절 점액낭염 시장 : 성장률 분석
세계의 슬관절 점액낭염 시장 실적 : 규모와 성장, 2019-2024
세계의 슬관절 점액낭염 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 슬관절 점액낭염 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 슬관절 점액낭염 시장 진단별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
영상 검사
기타 진단 검사
세계의 슬관절 점액낭염 시장 : 치료별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
약
치료
수술
기타 치료법
세계의 슬관절 점액낭염 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원과 진료소
진단 센터
연구 센터
학술기관
기타 최종사용자
세계의 슬관절 점액낭염 시장 : 하위 세분화 영상 검사 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
X선
MRI(자기공명영상)
초음파
세계의 슬관절 점액낭염 시장 : 하위 세분화 기타 진단 검사(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
신체검사
관절액 흡인
혈액 검사
제7장 지역별·국가별 분석
세계의 슬관절 점액낭염 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 슬관절 점액낭염 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
슬관절 점액낭염 시장 : 경쟁 구도
슬관절 점액낭염 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Medtronic plc
Eli Lilly and Company
Amgen Inc
Gilead Sciences Inc.
Stryker Corporation
Regeneron Pharmaceuticals Inc.
Biogen Inc.
Vertex Pharmaceuticals Incorporated
Zimmer Biomet Holdings Inc.
DePuy Synthes Inc.
Arthrex Inc.
Globus Medical Inc.
Bioventus LLC
Exactech Inc.
Genentech Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
슬관절 점액낭염 시장 2029 : 새로운 기회를 제공하는 국가
슬관절 점액낭염 시장 2029 : 새로운 기회를 제공하는 부문
슬관절 점액낭염 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Knee bursitis occurs when one or more of the small, fluid-filled sacs near the knee joint become inflamed. These sacs, called bursae, cushion and reduce friction between tissues such as bones, tendons, and muscles. Inflammation of these bursae leads to symptoms such as pain, swelling, and limited movement in the knee.
Diagnosis of knee bursitis typically involves imaging tests such as ultrasound or MRI scans. These tests help visualize inflammation and fluid buildup in the bursae surrounding the knee joint. Treatment options include medication and, in some cases, surgery. These treatments are utilized by hospitals, clinics, diagnostic centers, research institutions, academic establishments, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The knee bursitis research report is one of a series of new reports from The Business Research Company that provides knee bursitis market statistics, including the knee bursitis industry's global market size, regional shares, competitors with a knee bursitis market share, detailed knee bursitis market segments, market trends and opportunities, and any further data you may need to thrive in the knee bursitis industry. This knee bursitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The knee bursitis market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.86 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to an aging population, increased participation in sports and physical activities, improved diagnostic techniques, improved access to healthcare services, and education programs for healthcare professionals and patients.
The knee bursitis market size is expected to see strong growth in the next few years. It will grow to $3.72 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increased awareness campaigns about prevention and management, growth in disposable income, rising healthcare expenditure, and increasing awareness and diagnosis of knee bursitis. Major trends in the forecast period include advancements in diagnostic techniques, the development of novel therapies, advancements in research and development activities, and telemedicine and remote monitoring.
The forecast of 6.8% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of therapeutic ultrasound machines and corticosteroid injection kits sourced from South Korea and Italy, thereby prolonging pain management timelines and elevating orthopedic clinic expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing prevalence of bone-related diseases, such as osteoporosis, arthritis, and bone cancer, is expected to drive the expansion of the knee bursitis market in the future. These diseases affect the skeletal system's structure, strength, and functionality, and are increasingly prevalent due to factors such as aging populations, sedentary lifestyles, poor nutrition, and environmental changes. Conditions such as osteoarthritis and rheumatoid arthritis can lead to knee bursitis by causing inflammation and excessive pressure on the knee bursa, resulting in pain, swelling, and reduced joint function. For example, Healthy Bones Australia projected in September 2022 that Australia would have 6.2 million individuals aged 50 and above suffering from osteoporosis or osteopenia in 2022, highlighting the significant impact of poor bone health on knee-related conditions. Therefore, the rising prevalence of bone-related diseases is a key driver of growth in the knee bursitis market.
The anticipated growth of the knee bursitis market is expected to be driven by the increasing diabetic population in the coming years. Diabetes, a chronic condition characterized by the body's inability to regulate blood sugar levels effectively, results from insufficient insulin production or ineffective insulin use. Factors contributing to the rise in diabetes cases include sedentary lifestyles, unhealthy dietary habits, and genetic predispositions. Diabetic individuals are at higher risk of developing knee bursitis due to inflammation caused by prolonged pressure on the knees, impaired immune function, or complications related to diabetes. For instance, a July 2021 report by the International Diabetes Federation projected a substantial increase in the global diabetic population, estimating 643 million people living with diabetes by 2030 and 783 million by 2045. Therefore, the expanding diabetic population is a key driver behind the expected growth of the knee bursitis market.
The growing diabetic population is expected to drive the growth of the knee bursitis market in the future. Diabetes is a chronic condition in which the body struggles to regulate blood sugar levels due to either insufficient insulin production or ineffective insulin use. The rise in diabetes cases is linked to factors such as sedentary lifestyles, poor dietary habits, and genetic factors. Diabetic individuals may develop knee bursitis as a result of inflammation from prolonged pressure on the knees, weakened immune function, or diabetes-related complications. For example, in June 2024, a report from the National Health Service (NHS), a UK-based public health organization, revealed that in 2023, the number of people registered with pre-diabetes rose to 3,615,330, up from 3,065,825 in 2022, an 18% increase. Therefore, the growing diabetic population is fueling the expansion of the knee bursitis market.
Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc
North America was the largest region in the knee bursitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the knee bursitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The knee bursitis market consists of revenues earned by entities by providing services such as medical consultation, medication management, surgical intervention, and rehabilitation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The knee bursitis market also includes sales of knee braces and supports, cold packs and heat wraps, anti-inflammatory medications, and corticosteroid injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Knee Bursitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on knee bursitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for knee bursitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The knee bursitis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Diagnosis: Imaging Test; Other Diagnosis Tests
2) By Treatment: Medication; Therapy; Surgery; Other Treatments
3) By End User: Hospitals And Clinics; Diagnostic Centers; Research Centers; Academic Institutes; Other End Users
Subsegments:
1) By Imaging Test: X-Ray; MRI (Magnetic Resonance Imaging); Ultrasound
2) By Other Diagnosis Tests: Physical Examination; Aspiration Of Joint Fluid; Blood Tests
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Knee Bursitis Market Characteristics
3. Knee Bursitis Market Trends And Strategies
4. Knee Bursitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Knee Bursitis Growth Analysis And Strategic Analysis Framework
5.1. Global Knee Bursitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Knee Bursitis Market Growth Rate Analysis
5.4. Global Knee Bursitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Knee Bursitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Knee Bursitis Total Addressable Market (TAM)
6. Knee Bursitis Market Segmentation
6.1. Global Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Imaging Test
Other Diagnosis Tests
6.2. Global Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medication
Therapy
Surgery
Other Treatments
6.3. Global Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Centers
Research Centers
Academic Institutes
Other End Users
6.4. Global Knee Bursitis Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
X-Ray
MRI (Magnetic Resonance Imaging)
Ultrasound
6.5. Global Knee Bursitis Market, Sub-Segmentation Of Other Diagnosis Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Physical Examination
Aspiration Of Joint Fluid
Blood Tests
7. Knee Bursitis Market Regional And Country Analysis
7.1. Global Knee Bursitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Knee Bursitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Knee Bursitis Market
8.1. Asia-Pacific Knee Bursitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Knee Bursitis Market
9.1. China Knee Bursitis Market Overview
9.2. China Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Knee Bursitis Market
10.1. India Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Knee Bursitis Market
11.1. Japan Knee Bursitis Market Overview
11.2. Japan Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Knee Bursitis Market
12.1. Australia Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Knee Bursitis Market
13.1. Indonesia Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Knee Bursitis Market
14.1. South Korea Knee Bursitis Market Overview
14.2. South Korea Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Knee Bursitis Market
15.1. Western Europe Knee Bursitis Market Overview
15.2. Western Europe Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Knee Bursitis Market
16.1. UK Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Knee Bursitis Market
17.1. Germany Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Knee Bursitis Market
18.1. France Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Knee Bursitis Market
19.1. Italy Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Knee Bursitis Market
20.1. Spain Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Knee Bursitis Market
21.1. Eastern Europe Knee Bursitis Market Overview
21.2. Eastern Europe Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Knee Bursitis Market
22.1. Russia Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Knee Bursitis Market
23.1. North America Knee Bursitis Market Overview
23.2. North America Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Knee Bursitis Market
24.1. USA Knee Bursitis Market Overview
24.2. USA Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Knee Bursitis Market
25.1. Canada Knee Bursitis Market Overview
25.2. Canada Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Knee Bursitis Market
26.1. South America Knee Bursitis Market Overview
26.2. South America Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Knee Bursitis Market
27.1. Brazil Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Knee Bursitis Market
28.1. Middle East Knee Bursitis Market Overview
28.2. Middle East Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Knee Bursitis Market
29.1. Africa Knee Bursitis Market Overview
29.2. Africa Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Knee Bursitis Market Competitive Landscape And Company Profiles
30.1. Knee Bursitis Market Competitive Landscape
30.2. Knee Bursitis Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
31. Knee Bursitis Market Other Major And Innovative Companies
31.1. Medtronic plc
31.2. Eli Lilly and Company
31.3. Amgen Inc
31.4. Gilead Sciences Inc.
31.5. Stryker Corporation
31.6. Regeneron Pharmaceuticals Inc.
31.7. Biogen Inc.
31.8. Vertex Pharmaceuticals Incorporated
31.9. Zimmer Biomet Holdings Inc.
31.10. DePuy Synthes Inc.
31.11. Arthrex Inc.
31.12. Globus Medical Inc.
31.13. Bioventus LLC
31.14. Exactech Inc.
31.15. Genentech Inc.
32. Global Knee Bursitis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Knee Bursitis Market
34. Recent Developments In The Knee Bursitis Market
35. Knee Bursitis Market High Potential Countries, Segments and Strategies
35.1 Knee Bursitis Market In 2029 - Countries Offering Most New Opportunities
35.2 Knee Bursitis Market In 2029 - Segments Offering Most New Opportunities
35.3 Knee Bursitis Market In 2029 - Growth Strategies
